A NAAT test in the U.S. typically runs $50–$150, with cash prices ranging $25–$300 based on setting, turnaround, and insurance.
NAAT stands for nucleic acid amplification test. It’s the lab method behind PCR and similar molecular assays that look for viral or bacterial genetic material. In plain terms, it’s the lab work that finds tiny bits of RNA or DNA and amplifies them so the machine can read a clear “yes” or “no.” NAATs are widely used for COVID-19, flu, and many STI panels. The draw of NAAT is sensitivity: it can pick up low levels of a pathogen when antigen screens miss. The trade-off is price and logistics, since NAAT often needs certified equipment, a trained team, and a sample run in batches.
Quick Price Snapshot By Setting
Here’s a broad view of what people pay or what payers allow. These aren’t quotes; they’re typical ranges seen across clinics, pharmacies, and lab fee schedules. Insurance rules, in-network status, and location swing the bill.
| Setting | Typical Price | What’s Usually Included |
|---|---|---|
| Retail Clinic Or Pharmacy | $25–$150 cash; often plan pricing if in-network | Sample collection, on-site rapid NAAT or send-out PCR, basic result note |
| Urgent Care | $75–$250 test fee; visit fee may apply | Visit, exam code, NAAT (PCR or rapid NAAT), portal results |
| Hospital-Based Lab | $100–$300+ list price; insurer allowance is lower | Specimen collection, lab processing, result in EHR/portal |
| Independent Reference Lab | $50–$150 allowed amounts common for single-target PCR | Lab fee for NAAT; ordering provider may bill collection |
| Multiplex NAAT (COVID + Flu) | $120–$250 allowed amounts; higher list price | One swab, multiple targets (e.g., SARS-CoV-2, Flu A/B) |
| STI NAAT (e.g., CT/GC) | $50–$200 per panel depending on targets | Urine or swab, lab processing, result to ordering clinic |
What Counts As A NAAT
NAAT covers PCR and related molecular methods that copy genetic material to detectable levels. For respiratory testing, public guidance describes NAAT as the “gold standard” for detecting SARS-CoV-2, with strong sensitivity compared with antigen screens. See the CDC’s overview of NAAT vs. antigen testing for context on accuracy, turnarounds, and when confirmatory testing helps.
NAAT Test Cost — Typical Prices And What Affects Them
Prices break down into two buckets: what a lab charges and what a payer allows. Many consumers only see a single line on a receipt, yet the real cost reflects multiple moving parts: the instrument run, reagents, controls, labor, overhead, and sometimes a separate swab-collection code. Cash prices at retail clinics for rapid combo tests can post around the cost of a typical office copay, while send-out PCR tends to sit closer to triple digits. Medicare’s fee schedule anchors lab allowances near the lower end, and commercial plans cluster around those benchmarks with regional tweaks.
Benchmarks From Public Schedules
Medicare’s Clinical Lab Fee Schedule lists allowed amounts for common molecular codes. One widely used code for SARS-CoV-2 RT-PCR (CPT 87635) shows an allowed rate near the low-$50s on many current schedules. Multiplex panels that hit COVID and flu (CPT 87636) pay more since the test targets multiple pathogens in one run. You can spot those reference figures in a published fee schedule that lists RT-PCR at $51.31 and multiplex at $142.63 for 2024. That doesn’t mean every patient pays those amounts; it sets a typical insurer allowance many contracts reference. See a sample schedule with those values in this Medicare rate table.
Why Two People Get Two Different Bills
Network status, site of care, and the type of NAAT shift the total. The same PCR at an independent lab can show a lower allowed amount than the identical assay billed through a hospital lab. A multiplex panel costs more than a single-target test by design. Add an office visit, and the facility can add a separate evaluation code. Rapid point-of-care NAATs trade speed for volume; the device runs fewer samples at once, which bumps per-test costs in some settings.
Accuracy, Turnaround, And Why That Matters For Cost
Labs batch PCR runs to balance speed, reagent use, and staffing. During high demand, runs leave the instrument faster; during quiet weeks, a lab may wait to fill a plate, which can slow results. That timing can guide which test you pick. If you only need a travel document in 24–48 hours, a send-out PCR with portal delivery may be perfect. If you need a same-day answer to start treatment, a rapid NAAT at a clinic may be worth the higher sticker.
Insurance, Medicare, And Common Scenarios
Most health plans treat molecular respiratory testing like other outpatient labs: covered when medically necessary and ordered in-network. Cost-sharing depends on your plan design. During certain public programs, some tests had special coverage. Those programs change over time, so the best move is to check your insurer’s portal before you book. For seniors, consumer guidance from trusted nonprofits notes that Medicare continues to cover clinical COVID testing without cost-sharing when medically necessary, with at-home test coverage ending earlier. Your plan’s site will spell out the current rules; the CDC’s testing page remains a steady reference for when NAAT makes sense and how it compares to antigen screens.
Travel, Work, And School Requirements
Some destinations or workplaces ask for molecular proof with a lab report. In those cases, clinics usually steer you to PCR or a rapid NAAT that prints or posts a formal lab result. Cash prices vary widely based on speed and certificate formatting. Next, check whether a simple single-target test meets the rule or if a combo panel is required. Combo panels add cost with no added benefit if the rule only cites one pathogen.
How Providers Set NAAT Prices
Most lab teams look at reagent contracts, instrument service fees, throughput, and regional wages. If a lab runs many samples each day, it spreads fixed costs across a larger base, which helps the price. A low-volume point-of-care device at a small clinic carries higher per-test overhead. Then comes payers’ contract terms: an insurer’s allowed amount often lands well below a list price. Self-pay discounts and assistance programs can bring the bill down for uninsured patients who ask at the desk.
Ways To Trim Your Bill
- Use in-network sites. Search your plan’s directory for labs and retail clinics that process NAATs.
- Match the test to the need. If a single-target PCR meets a travel rule, skip a pricier multiplex panel.
- Ask for self-pay rates. Many clinics post a cash price that beats an out-of-network claim.
- Check community clinics. Federally supported health centers sometimes offer low-cost testing slots.
- Confirm the timeline. If you need results in hours, book a rapid NAAT; if a day or two is fine, a standard send-out can save money.
What The Price Includes
A typical bill bundles a specimen collection code, the NAAT itself, and result reporting. If a clinician evaluates symptoms, a visit code appears as a separate line. If you receive treatment during the same visit, the pharmacy charge posts separately. Many retail clinics roll the rapid NAAT and the visit into one price; hospital-based clinics usually separate them.
Real-World Price Anchors You Can Use
Public health pages frame NAAT as the most sensitive option for COVID-19, and they place it in the $75–$100 band in general lab comparisons, with antigen tests landing lower. That broad range lines up with what many clinics show for simple send-out PCR. Add speed, a combo panel, or a facility fee, and the number goes up. The CDC compares methods and includes cost bands here: overview of SARS-CoV-2 testing. For what payers allow, Medicare’s fee schedule sits near $51 for a single-target SARS-CoV-2 PCR and around $143 for a multiplex that hits COVID and flu. That file is a helpful yardstick when you see a list price that looks steep.
When A NAAT Is Worth The Extra Spend
Three use cases justify the higher fee. First, when early detection changes treatment timing, such as antivirals that need a quick start. Second, when a gatekeeper needs a lab-backed result, such as travel or surgical clearance. Third, when rapid antigen keeps turning negative and symptoms persist, a molecular assay can settle the question. In each case, paying for the method that fits the decision saves time and repeat visits.
Fee Codes, Line Items, And Sample Bills
Labs and clinics use standardized codes that map to payer allowances. The molecular code for SARS-CoV-2 RT-PCR (CPT 87635) appears on many claims. A dual-target panel for COVID and flu commonly uses CPT 87636. Specimen collection at a clinic can bill under special collection codes in certain programs. While consumers don’t need to memorize codes, knowing that a multiplex carries a higher allowance can explain a bigger number on the statement. Official primers on NAAT vs. antigen are here: the FDA’s test basics page lays out how molecular tests detect viral RNA.
Sample Itemized Costs You Might See
These examples show common lines. Numbers swing by state and contract; think of them as a map, not a quote.
| Line Item | Typical Amount | When It Appears |
|---|---|---|
| Single-Target RT-PCR (CPT 87635) | ~$50 allowed on Medicare schedules; commercial varies | Standard lab PCR with portal result |
| Multiplex PCR (CPT 87636) | ~$140 allowed on Medicare schedules; commercial varies | One swab, COVID + Flu A/B in a single run |
| Specimen Collection | $0–$30 when billed; often bundled or waived in retail settings | Clinic or lab swab fee; may not appear at all sites |
| Clinic Visit Fee | $0–$150 depending on plan and site | Urgent care or hospital-based clinic visits |
| Rush / Rapid NAAT | $75–$200 cash in retail/urgent care settings | Same-day instrument run on-site |
STI Panels And Other NAAT Use Cases
NAAT isn’t only for respiratory infections. Clinics rely on molecular assays for chlamydia, gonorrhea, and trichomonas using urine or swab samples. Prices vary with the number of targets and the lab. Research on workflows in public clinics pegs per-test costs in the tens of dollars, while commercial list prices that consumers see run higher. If your clinic uses a standing program, your out-of-pocket can be low.
Simple Steps To Get A Fair Price
- Pick your target. Ask whether you need a single-pathogen result or a combo panel.
- Pick your speed. Decide if you need a result in under an hour, under a day, or within two days.
- Pick your site. Search your insurer’s in-network directory for retail clinics and labs that run NAATs.
- Ask for cash rates. If you’re out of network, a posted self-pay price can be lower than a claim.
- Keep the proof. For travel or HR, confirm that the lab report format matches the requirement.
Bottom Line Price Ranges
For a single-target respiratory PCR done through a typical clinic and lab, many insured patients see little or no out-of-pocket when it’s medically necessary and in-network. Self-pay prices often fall between $50 and $150 for send-out PCR, with rapid NAATs and multiplex panels running higher. If you need a same-day certificate for travel or treatment decisions, budget on the upper end. If time is flexible, a standard send-out through an in-network lab usually lands near the middle of the range.
Sources You Can Trust
For method basics and when to choose NAAT, read the CDC’s page on testing types and accuracy. For payer benchmarks that anchor many contracts, check a Medicare fee table that lists example amounts for common molecular codes, including $51.31 for single-target RT-PCR and $142.63 for a COVID + flu multiplex on a 2024 schedule: CLFS reference. For a plain-language primer on molecular vs. antigen methods, the FDA’s consumer note on test basics lays out the differences.
